Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Lumacyte is a pioneering biotechnology company focused on transforming cell analysis through its innovative Laser Force Cytology (LFC™) platform. This proprietary technology enables rapid, label-free, single-cell characterization by measuring the optical and mechanical properties of cells. Lumacyte's solutions aim to accelerate biopharmaceutical development and manufacturing processes, including cell line development, viral vector production, and cell therapy manufacturing, by providing deeper insights into cell health, viability, and function without the need for traditional staining methods. Their instruments offer significant advantages in terms of speed, automation, and data richness, empowering scientists and researchers to make more informed decisions faster.
Serves as the central hub for research and development, engineering, manufacturing of their LFC™ instruments, and corporate operations.
Likely houses advanced laboratories equipped for optical engineering, microfluidics, and cell biology research, alongside cleanroom facilities for instrument assembly.
Emphasizes innovation, collaboration, and scientific rigor, with a focus on translating cutting-edge research into practical solutions for the biopharmaceutical industry. Employees often share a passion for advancing science and technology.
The Charlottesville location provides access to a skilled talent pool from local universities and a supportive biotech ecosystem, crucial for Lumacyte's growth and innovation in cell analysis technology.
While Lumacyte's primary operations are based in the USA, their technology and products serve the global biopharmaceutical market. Their global reach is facilitated through direct sales efforts, strategic partnerships, and potentially distribution networks to support research institutions, pharmaceutical companies, and contract development and manufacturing organizations (CDMOs) worldwide. They participate in international conferences and collaborations to extend their influence.
630 Research Road
Charlottesville
Virginia
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, LumaCyte' leadership includes:
LumaCyte has been backed by several prominent investors over the years, including:
Based on publicly available information, Lumacyte's executive team has remained stable over the past 12 months, with no major widely reported new hires or departures at the C-suite or VP level. The company continues to build out its team in various functions as it grows.
Discover the tools LumaCyte uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Lumacyte likely uses standard corporate email formats. The most common patterns for companies of its size and type are [first_initial][last]@[domain] or [first].[last]@[domain].
[first_initial][last]@lumacyte.com (e.g., jsmith@lumacyte.com) or [first].[last]@lumacyte.com (e.g. john.smith@lumacyte.com)
Format
shart@lumacyte.com
Example
80%
Success rate
Business Wire • March 27, 2024
Lumacyte announced the launch of its new Radiance™ viability capability for its Laser Force Cytology (LFC™) platform. This advancement enhances real-time, label-free cell analysis, providing critical insights for bioprocessing and cell therapy development by integrating optical force measurements with fluorescence detection....more
PR Newswire • March 1, 2023
Lumacyte, Inc., an advanced bioanalytical instrumentation company, announced the close of its $16 million Series A financing round. The round was led by Biospring Partners, with participation from existing and new investors including Phoenix Venture Partners II and Madrona Venture Group. The funds will be used to accelerate commercialization of its LFC™ platform....more
PR Newswire • September 21, 2022
Lumacyte announced a partnership with the Pharmaceutical Research and Manufacturers of America (PhRMA) to highlight its LFC™ technology for viral vector analytics. The collaboration aims to demonstrate the platform's capabilities in improving the efficiency and quality control of gene therapy manufacturing....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including LumaCyte, are just a search away.